ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

What’s the excitement over gene therapy? – Genetic Literacy Project

Continue reading

2017-11-06 Michael Zand NEWS

Comparing Editas Medicine (NASDAQ:EDIT) & Crispr Theraptc (CRSP) – The Ledger Gazette

Comparing Editas Medicine (NASDAQ:EDIT) & Crispr Theraptc (CRSP)The Ledger GazetteCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 (Cas9) or CRISPR from Prevotella and Francise… Continue reading

2017-11-06 Michael Zand NEWS

Cellular Biomedicine Group (CBMG) Reports Strategic Partnership with Thermo Fischer Scientfic (TMO) China to … – StreetInsider.com

Cellular Biomedicine Group (CBMG) Reports Strategic Partnership with Thermo Fischer Scientfic (TMO) China to …StreetInsider.com“Break-through cell therapy technology such as CAR-T provides unprecedented medical needs to cancer patients, yet the succe… Continue reading

2017-11-06 Michael Zand NEWS

Timing, Sequencing of Immunotherapy Combination May Improve Mesothelioma Response – MesotheliomaHelp.org (blog)

Timing, Sequencing of Immunotherapy Combination May Improve Mesothelioma ResponseMesotheliomaHelp.org (blog)In September, MesotheliomaHelp reported on researchers taking a closer look at immune cells to help identify those patients who may respond best… Continue reading

2017-11-06 Michael Zand NEWS

Baby gene therapy study offers hope for fatal muscle disease – Bennington Banner


Genetic Literacy Project

What’s the excitement over gene therapy?
Genetic Literacy Project
Gene therapy has been in the news a lot of late as a potential cure for a variety of genetic diseases. The biggest breakthrough involved a unanimous backing from U.S. Food and Drug Administration’s advisory panel for a new gene therapy from Spark …

Continue reading

2017-11-06 Michael Zand NEWS

Baby gene therapy study offers hope for fatal muscle disease – Bennington Banner


Bennington Banner

Baby gene therapy study offers hope for fatal muscle disease
Bennington Banner
Dr. Jerry Mendell of the Center for Gene Therapy at Nationwide Children’s Hospital in Columbus, Ohio. Mendell led a small study of gene therapy in babies born with a usually fatal neuromuscular disease and reported Nov. 1 that the experiment extended …

Continue reading

2017-11-06 Michael Zand NEWS

Sarepta Therapeutics (SRPT): FDA Clears GALGT2 Gene Therapy Program – William Blair – StreetInsider.com


Bennington Banner

Baby gene therapy study offers hope for fatal muscle disease
Bennington Banner
Dr. Jerry Mendell of the Center for Gene Therapy at Nationwide Children’s Hospital in Columbus, Ohio. Mendell led a small study of gene therapy in babies born with a usually fatal neuromuscular disease and reported Nov. 1 that the experiment extended …

Continue reading

2017-11-06 Michael Zand NEWS

Novartis files for approval of its new CAR-T cell therapy in Europe – The Pharma Letter

The Pharma LetterNovartis files for approval of its new CAR-T cell therapy in EuropeThe Pharma LetterIn August, Swiss pharma giant Novartis won the race to market a CAR T-cell-directed therapy, receiving US Food and Drug Administration approval for its… Continue reading

2017-11-06 Michael Zand NEWS
  • 1
  • …
  • 940
  • 941
  • 942
  • 943
  • 944
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Sarepta Therapeutics (SRPT): FDA Clears GALGT2 Gene Therapy Program – William Blair
StreetInsider.com
William Blair analyst, Tim Lugo, reiterated his Outperform rating on shares of Sarepta Therapeutics (NASDAQ: SRPT) after the company announced the FDA had approved an investigational new drug (IND) application for its GALGT2 gene therapy program …
Sarepta Therapeutics and Nationwide Children’s Hospital Announce FDA Clearance of IND for Micro-Dystrophin Gene …GlobeNewswire (press release)

all 4 news articles »